Overview of open clinical trials in Centre for Dermatology 2017

• A phase Ib, blinded, randomized, multicenter, multiple-ascending-dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of UTTR 1147A, administered by subcutaneous injection in patients with non-healing neuropathic diabetic foot ulcers
• Multi-center, Double-blind, Randomised, Placebo-controlled, Phase IIa Study to Investigate Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacogenomics of Multiple Intravenous Doses of BI 655130 in Patients With Palmoplantar Pustulosis (PPP)